Holen Sie sich die Stockscreener-App
25.00
0.04%
0.01
Handel nachbörslich:
24.75
-0.25
-1.00%
Schlusskurs vom Vortag:
$24.99
Offen:
$25
24-Stunden-Volumen:
325.42K
Relative Volume:
1.02
Marktkapitalisierung:
$682.11M
Einnahmen:
$79.95M
Nettoeinkommen (Verlust:
$-4.60M
KGV:
-139.90
EPS:
-0.1787
Netto-Cashflow:
$10.19M
1W Leistung:
+10.72%
1M Leistung:
+48.81%
6M Leistung:
+20.60%
1J Leistung:
+111.33%
1-Tages-Spanne:
$24.56
$25.59
1-Wochen-Bereich:
$23.23
$25.99
52-Wochen-Spanne:
$11.09
$25.99
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
25.00 | 681.84M | 79.95M | -4.60M | 10.19M | -0.1787 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Eton Pharmaceuticals, Inc. (ETON) stock price, news, quote and history - Yahoo Finance UK
How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation Targets - Yahoo Finance
(ETON) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Eton Pharmaceuticals Inc (ETON) Stock Price, Quote, News & History - Benzinga
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Eton Pharmaceuticals (ETON) soars 6.7%: Is further upside left in the stock? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week HighHere's Why - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 14.4% in March - MarketBeat
JPMorgan Chase & Co. Has $7.64 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
ETON Stock Price, Quote & Chart | ETON PHARMACEUTICALS INC (NASDAQ:ETON) - ChartMill
Layoff Watch: Can Eton Pharmaceuticals Inc maintain sales growth2026 Big Picture & Community Verified Trade Alerts - baoquankhu1.vn
Breakout Move: Is Eton Pharmaceuticals Inc forming a breakout patternMarket Activity Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
The Insider Report: Markets Wade into Geopolitical Abyss - Benzinga
Eton Pharmaceuticals (ETON) price target increased by 25.56% to 38.42 - MSN
Vanguard (ETON) Disaggregates Holdings, Reports 0 Shares - Stock Titan
Eton Pharmaceuticals (ETON) Jumps 6.7%: Does the Stock Have More Room to Grow? - Bitget
Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Does Eton Pharmaceuticals (ETON) have the potential to rally 49.25% as Wall Street analysts expect? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week High After Analyst Upgrade - MarketBeat
Recent price trend in Eton Pharmaceuticals (ETON) is your friend, here's why - MSN
H.C. Wainwright raises Eton Pharmaceuticals price target on growth goals By Investing.com - Investing.com Canada
Dow Update: Is Eton Pharmaceuticals Inc still a buy after recent gainsMarket Performance Report & Consistent Income Trade Recommendations - baoquankhu1.vn
Zacks Research Upgrades Eton Pharmaceuticals (NASDAQ:ETON) to Strong-Buy - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path - TipRanks
Eton Pharmaceuticals receives Investment Bank Analyst Rating Update By Investing.com - Investing.com Canada
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
B. Riley Financial Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect? - sharewise.com
Does Eton Pharmaceuticals (ETON) Have a Chance to Surge 49.25% According to Wall Street Analysts' Predictions? - Bitget
B.Riley raises Eton Pharmaceuticals stock price target on strong Q4 results - Investing.com Canada
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript - Insider Monkey
Eton Pharma 2025 Financial Results & 2026 Outlook | Product Launches Drive GrowthNews and Statistics - IndexBox
Portfolio Update: Can Eton Pharmaceuticals Inc. lead its sector in growth2026 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Eton Pharmaceuticals 2023 Financial Results: Revenue, Net Income, and Key Financial Highlights - Minichart
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals 2025 Annual Report: Rare Disease Drug Portfolio, Regulatory Pathways, and Risk Factors Overview - Minichart
Is Eton Pharmaceuticals Inc a cyclical or defensive stock2026 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Q4 earnings lag estimates - MSN
Eton Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Eton Pharmaceuticals, Inc. (ETON) Q4 Results Fall Short of Projections - Bitget
ETON: 2025 revenue more than doubled year-over-year, with strong margin gains and robust growth outlook - TradingView
Eton Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Eton Pharma (ETON) Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Eton Pharmaceuticals Q4 2025 beats EPS, stock rises - Investing.com
Eton Pharmaceuticals earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Eton Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - tradingview.com
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates - Yahoo Finance
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):